NA
GSK icon

Nordwand Advisors’s GSK GSK Stock Holding History

Nordwand Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,171
Closed -$315K – 152
2024
Q2 		$315K Sell
8,171
-10,687
-57% -$450K 0.14% 21
2024
Q1 		$808K Sell
18,858
-28,161
-60% -$1.16M 0.31% 31
2023
Q4 		$1.74M Hold
47,019
– – 0.46% 24
2023
Q3 		$1.7M Buy
+47,019
New +$1.67M 0.34% 22

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordwand Advisors's GSK Position: Q3 2024 in Review

Nordwand Advisors sold out of GSK (GSK) in Q3 2024, closing a stake of 8,171 shares — an estimated $315K sold.

Nordwand Advisors first reported a position in GSK in Q3 2023 and held it in 4 quarters. The position peaked at $1.74M in Q4 2023. 900 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Nordwand Advisors reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Nordwand Advisors sold 8,171 GSK shares in Q3 2024, an estimated $315K.
  • Nordwand Advisors first reported a position in GSK in Q3 2023 and held it in 4 quarters.
  • Nordwand Advisors's GSK position peaked at $1.74M in Q4 2023.
  • 900 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Nordwand Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.